Acute Pancreatitis in HIV-Infected Patients: Are Etiologies Changing Since the Introduction of Protease Inhibitor Therapy?

Nursing

Volumn 27, Issue 1, 1997, Pages

  Bush, Zachary M ^a   Kosmiski, Lisa A ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute pancreatitis; HIV infection; Hypertriglyceridemia; Protease inhibitors

Indexed keywords

PROTEINASE INHIBITOR;

ACUTE DISEASE; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; MALE; PANCREATITIS; RETROSPECTIVE STUDY;

ACUTE DISEASE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; PANCREATITIS; RETROSPECTIVE STUDIES;

EID: 1542755229     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cappell MS, Marks M. Acute pancreatitis in HIV-seropositive patients: a case control of 44 patients. Am J Med. 1995; 98:243-248.
2. Dutta SK, Ting CD, Lai LL. Study of prevalence, severity, and etiologic factors associated with acute pancreatitis in patients infected with human immunodeficiency virus. Am J Gastroenterol. 1997; 92:2044-2048.
3. Miller TL, Winter HS, Luginbuhl LM, et al. Pancreatitis in pediatric human immunodeficiency virus infection. J Pediatr. 1992; 120:223-227.
4. Dassopoulos T, Ehrenpreis ED. Acute pancreatitis in human immunodeficiency virus-infected patients: a review. Am J Med. 1999; 107:78-84.
5. Toskes P. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990; 19:783-791.
6. Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995; 90:2134-2139.
7. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on the detection, evaluation, and treatment of high cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-2497.
8. Manocha AP, Sossenheimer M, Martin SP, et al. Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS). Am J Gastroenterol. 1999; 94:784-789.
9. Palella Jr, FJ Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338:853-860.
10. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS. 1999; 13:2493-2505.
11. Mirete G, Masia M, Gutierrez F, et al. Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS. Eur J Clin Microbiol Infect Dis. 1998; 17:810-811.
12. Perry RC, Cushing HE, Deeg MA, et al. Ritonavir, triglycerides and pancreatitis. Clin Infect Dis. 1999; 28:161-162.
13. Martino VD, Ezenfis J, Benhamou Y, et al. Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge. AIDS. 1999; 13:1421-1423.
14. Tsiodras S, Mantzoros C, Hammer S, et al. Effects of protease inhibitors on hyperglycemia, hyperlipidemia and lipodystrophy: a five year cohort study. Arch Intern Med. 2000; 160:2050-2056.
15. Chait A, Brunzell JD. Chylomicronemia syndrome. Adv Intern Med. 1992; 37:249-273.
16. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996; 3:213-219.
17. Dube MP, Sprecher D, Henry WK, et al. Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin Infect Dis. 2000; 31:1216-1224.